The proposal comes from the National Institute for Health and Care Excellence, known as NICE, which assesses which treatments and tests offer good value for England’s publicly funded health service. The NHS is the National Health Service.
Its draft recommendations cover adults with persistent acid reflux and several other risk factors, as well as checks for people already diagnosed with a condition called Barrett’s esophagus. They would allow suitable patients to be tested at a family doctor’s practice or a community testing center.
For patients, that could mean an easier first appointment. Daylight Post found that moving the first check closer to home would still leave patients needing hospital follow-up: an abnormal result still needs a hospital test, in a service where more than one in four people on the gastroscopy waiting list had already waited at least six weeks.
Why long-lasting heartburn can lead to a check
Acid reflux happens when stomach contents come back up into the food pipe, the tube carrying food from the mouth to the stomach. It can cause the burning feeling called heartburn.
Repeated reflux can be linked to changes in the cells lining the lower food pipe. These changes are called Barrett’s esophagus. Having Barrett’s raises the risk of a type of food-pipe cancer, but most people with the condition do not develop cancer.
The proposal does not offer a cancer test to everyone who gets heartburn. A clinician would consider lasting reflux alongside other risks, such as age, smoking, being overweight or a family history of the condition. People whose symptoms call for an urgent investigation for suspected cancer would continue on that urgent route.
A smaller first step, with follow-up when needed
During the capsule sponge test, a person swallows a small capsule attached to a thread. The capsule dissolves in the stomach and releases a sponge. A trained health worker draws it back up using the thread, collecting cells that are sent to a laboratory.
The test does not need sedation, the medicine sometimes used to help people relax during a hospital examination. That makes it easier to provide outside hospital. Removing the sponge can be uncomfortable, and a sore throat is a possible side effect.
A positive result is not a final cancer diagnosis. It means the person needs an endoscopy, also called a gastroscopy in this setting. A thin tube with a camera is passed through the mouth to examine the food pipe and stomach. Samples of tissue can be taken to find out what is wrong.
A negative result cannot rule out every problem. NICE says people should be told what changes in symptoms to look out for and when to seek further help. The test can also be used in planned follow-up for people with Barrett’s; that does not mean everyone would stop having camera tests.
Hospital capacity remains part of the story
We checked NHS England’s September diagnostic waiting data, published on November 12. The national gastroscopy waiting list stood at 72,797 at the end of the month. Of those waiting, 28.1% had waited six weeks or more from referral.
These figures cover gastroscopy for many reasons. They do not tell us how many people could have a sponge test instead, or how many would need a camera test after one. They therefore cannot be used to predict how much this proposal would shorten queues.
They do show why moving the first check into the community is only part of delivering care. Patients with concerning results need a clear route onward. NICE’s committee heard that pressure on endoscopy services can discourage referrals and delay routine monitoring for some people with Barrett’s.
Access also depends on who can reach an appointment. NICE’s equality assessment identifies possible benefits for people who live far from hospitals or find travel difficult. It also notes that food-pipe cancer is more common, and more often diagnosed after an emergency, among people in deprived areas. Whether wider community testing will reduce these inequalities still needs evidence.
When the proposal could become available
The consultation runs until December 7, with final guidance expected in February 2027. If the recommendations are confirmed, the NHS in England would have to fund the tests within 90 days of the final guidance for eligible patients when their clinician considers this the most suitable option.
That would make access less dependent on which area offers the test. The practical measure of success will be whether people can get both the initial check and any further investigation they need.
